Costs of generic drugs and outpatient services targeted
The government wants to cap prices for generic drugs as part of a package of measures to reduce rising health costs in Switzerland.
This content was published on
2 minutes
swissinfo.ch/urs
Interior Minister Alain Berset, whose portfolio includes health issues, on Friday presented plans to allow health insurers, health service providers and cantonal authorities to launch pilot projects to test innovative financing methods for hospital care or outpatient services.
The package will go to a consultation among political parties, organisations and institutions involved before parliament is due to discuss the final proposals. It is expected to lead to a savings of several hundred million francs per year, according to Berset.
He added that it won’t be easy to find support for all the proposed measures, given the ongoing dispute between insurers, doctors, the pharmaceutical industry and cantonal authorities, notably about a billing system for doctors.
Mixed reaction
In an initial reaction, the industry associations of Swiss pharmacistsExternal link and producers of generics have rejected the government proposal. They warned that patients would no longer be free to choose their favourite therapy.
For their part, the association of health insurers welcomed the plans , saying they were a step in the right direction.
SantésuisseExternal link notably called for cheaper drugs prices and more say in the construction of hospitals and nursing homes as well as increased cost transparency.
Financial caps
A second package of proposals is expected to be presented next year, including financial caps for medical costs, as recommended by a group of experts in 2016.
Overall health costs in Switzerland are about CHF80 billion ($82.6 billion) annually, including CHF30 billion covered by the mandatory health insurance plans.
The Swiss healthcare system is known for its excellent level of care, but is also among the most expensive in the world.
Ecological status of Swiss streams insufficient according to study
This content was published on
Pesticide use and obstructions of waterways have a particularly negative impact on sensitive organisms, completely absent in 70% of streams analysed.
Train line between Brig and Domodossola interrupted
This content was published on
One day after a derailment approximately 15 kilometres from the Swiss border, BLS is running buses for passengers between Preglia and Domodossola, in Italy.
Swiss football boss wants crackdown on individual hooligans
This content was published on
The head of the Swiss Football League says he prefers a harsher approach to individual hooligans rather than collective punishment measures affecting all fans.
Amherd: Council of Europe is ‘as urgently needed as ever’
This content was published on
The Swiss government emphasised on Sunday the vital role of the Strasbourg-based Council of Europe, 75 years after it was founded.
Swiss minister: Italy will back Switzerland in EU talks
This content was published on
Bern can count on the backing of Italy as it re-enters talks with the European Union on future relations, Viola Amherd says.
Student protestors at University of Lausanne continue pro-Palestine sit-in
This content was published on
Since Thursday, a hall on campus has been occupied by students calling for a boycott of Israeli academic institutions and a ceasefire in Gaza.
National conference divided on how to halt rising healthcare costs
This content was published on
The fifth Swiss national health conference on Monday centred on one major bugbear: costs. Attendees were divided on how to halt the rise.
This content was published on
The Swiss spend more from their own pockets for health care than any other nation, according to a survey for the price comparison website Comparis.
This content was published on
Interior Minister Alain Berset says he is willing to consider the introduction of a global budget for Switzerland’s healthcare system as part of efforts to reduce rising health costs.
This content was published on
In an era where health care is a subject of debate in many countries, is the Swiss system serving those on moderate to low incomes?
Novartis’s new $475,000 cancer drug among most expensive ever
This content was published on
Bruno Strigini, chief executive of oncology at Novartis, said: “We carefully considered the appropriate price and looked at many factors, including the medical and clinical value.” He was speaking on Wednesday shortly after the treatment was approved by the US Food and Drug Administration (FDA), which gave Novartis a green light to use the medicine…
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.